National Business

CALGARY — Calfrac Well Services Ltd. is postponing a vote on its recapitalization plan following an unsolicited takeover offer for the company by Texas-based Wilks Brothers LLC last week.

TORONTO — When Myriam Maguire sits down to design footwear for her fashion boutiques in Montreal and Toronto, glamour and special occasions are often on her mind.

NEW YORK — Amazon will hire another 100,000 people to keep up with a surge of online orders. The company said Monday that the new hires will help pack, ship or sort orders, working in part-time and full-time roles.

MONTREAL — The Renard diamond mine in northern Quebec is to reopen this month after being shut down in March as part of the province's mining lockdowns in response to the COVID-19 pandemic. Minority shareholder Osisko Gold Royalties Ltd.

TORONTO — Great Canadian Gaming Corp. says its properties in Halifax and Sydney, N.S., will reopen on Oct. 5 following a six-month closure due public health efforts to contain the COVID-19 pandemic.

WINNIPEG — Jeff Carney is retiring as president and chief executive of IGM Financial and IG Wealth Management due to health reasons. Carney says that he has been diagnosed with the early stages of Alzheimer’s disease.

NEW YORK — British perfume brand Jo Malone has apologized to Black actor John Boyega of “Star Wars” fame after cutting him out of the Chinese version of a cologne commercial he helped create.

TORONTO — Netflix and the Toronto International Film Festival have been an inseparable power couple for years, mastering the ways to get moviegoers talking, but during the pandemic their storied Hollywood relationship is on a break.

TOKYO — The criminal trial against Japanese automaker Nissan and its former executive Greg Kelly will open in Tokyo District Court on Tuesday. It’s the latest chapter in the unfolding scandal of Carlos Ghosn, a superstar at Nissan Motor Co.

LONDON — Oxford University announced Saturday it was resuming a trial for a coronavirus vaccine it is developing with pharmaceutical company AstraZeneca, a move that comes days after the study was suspended following a reported side-effect in a U.K.